Opportunity
DIBBS #SPE2DP-27-T-0217
DLA Request for Docusate Sodium Capsules
Posted
November 03, 2026
Respond By
November 09, 2026
Identifier
SPE2DP-27-T-0217
NAICS
424210
DLA Troop Support is seeking a small delivery of prescription docusate sodium capsules for its Medical Supply Chain Pharmaceutical FSA. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA; contact listed: James Mariani. - Product: 3 packages of docusate sodium capsules, USP, 10 mg, NSN 6505-00-163-7656; each package contains 100 unit doses. - Named approved sources: The Harvard Drug Group, L.L.C. (P/N NDC00904-7183-61) and AmerisourceBergen Drug Corp. (P/N NDC60687-0129-01). The notice identifies them as approved sources, not necessarily as manufacturers. - Requirements: Prescription-only product; store at 20–25°C (68–77°F), controlled room temperature. Delivery is FOB destination and required within 20 days after order. - Additional specifications: None stated in the provided material.
Description
DOCUSATE SODIUM CAPSUL (QTY: 3, NSN: 6505-00-163-7656, Purchase Request: 7018955368) Approved Sources: - CAGE: 1LEZ0, Part No: NDC00904-7183-61, Company: THE HARVARD DRUG GROUP, L.L.C. - CAGE: 1XUY5, Part No: NDC60687-0129-01, Company: AMERISOURCEBERGEN DRUG CORP